Beijing Tongrentang Co Ltd (600085) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Beijing Tongrentang Co Ltd (600085) has a cash flow conversion efficiency ratio of -0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-14.94 Million ≈ $-2.19 Million USD) by net assets (CN¥21.45 Billion ≈ $3.14 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600085 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Beijing Tongrentang Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Beijing Tongrentang Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Beijing Tongrentang Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beijing Tongrentang Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Uipath Inc
NYSE:PATH
|
0.088x |
|
Allfunds Group Ltd
AS:ALLFG
|
0.264x |
|
Hess Midstream Partners LP
NYSE:HESM
|
0.676x |
|
Hangcha Group Co Ltd
SHG:603298
|
0.026x |
|
Fujian Huoju Electronic
SHG:603678
|
-0.005x |
|
PTT Global Chemical Public Company Limited
BK:PTTGC
|
0.098x |
|
Dyno Nobel Ltd
AU:DNL
|
0.036x |
|
United Internet AG NA
XETRA:UTDI
|
0.056x |
Annual Cash Flow Conversion Efficiency for Beijing Tongrentang Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Beijing Tongrentang Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see Beijing Tongrentang Co Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥20.90 Billion ≈ $3.06 Billion |
CN¥760.99 Million ≈ $111.36 Million |
0.036x | -60.55% |
| 2023-12-31 | CN¥20.26 Billion ≈ $2.96 Billion |
CN¥1.87 Billion ≈ $273.57 Million |
0.092x | -44.96% |
| 2022-12-31 | CN¥18.45 Billion ≈ $2.70 Billion |
CN¥3.09 Billion ≈ $452.79 Million |
0.168x | -18.41% |
| 2021-12-31 | CN¥16.67 Billion ≈ $2.44 Billion |
CN¥3.43 Billion ≈ $501.39 Million |
0.206x | +46.92% |
| 2020-12-31 | CN¥15.55 Billion ≈ $2.27 Billion |
CN¥2.17 Billion ≈ $318.22 Million |
0.140x | -9.81% |
| 2019-12-31 | CN¥14.66 Billion ≈ $2.15 Billion |
CN¥2.27 Billion ≈ $332.72 Million |
0.155x | +16.85% |
| 2018-12-31 | CN¥14.53 Billion ≈ $2.13 Billion |
CN¥1.93 Billion ≈ $282.18 Million |
0.133x | +20.62% |
| 2017-12-31 | CN¥13.17 Billion ≈ $1.93 Billion |
CN¥1.45 Billion ≈ $212.02 Million |
0.110x | +27.08% |
| 2016-12-31 | CN¥12.08 Billion ≈ $1.77 Billion |
CN¥1.05 Billion ≈ $153.03 Million |
0.087x | +13.06% |
| 2015-12-31 | CN¥10.87 Billion ≈ $1.59 Billion |
CN¥832.47 Million ≈ $121.82 Million |
0.077x | -4.86% |
| 2014-12-31 | CN¥8.65 Billion ≈ $1.27 Billion |
CN¥696.01 Million ≈ $101.85 Million |
0.080x | -6.73% |
| 2013-12-31 | CN¥7.84 Billion ≈ $1.15 Billion |
CN¥676.40 Million ≈ $98.98 Million |
0.086x | -44.66% |
| 2012-12-31 | CN¥5.60 Billion ≈ $820.10 Million |
CN¥873.97 Million ≈ $127.89 Million |
0.156x | +37.69% |
| 2011-12-31 | CN¥4.81 Billion ≈ $704.01 Million |
CN¥544.91 Million ≈ $79.74 Million |
0.113x | -2.83% |
| 2010-12-31 | CN¥4.22 Billion ≈ $617.71 Million |
CN¥492.04 Million ≈ $72.00 Million |
0.117x | -27.34% |
| 2009-12-31 | CN¥3.91 Billion ≈ $572.59 Million |
CN¥627.69 Million ≈ $91.85 Million |
0.160x | +39.55% |
| 2008-12-31 | CN¥3.68 Billion ≈ $538.21 Million |
CN¥422.79 Million ≈ $61.87 Million |
0.115x | +221.08% |
| 2007-12-31 | CN¥3.38 Billion ≈ $494.65 Million |
CN¥121.02 Million ≈ $17.71 Million |
0.036x | -72.51% |
| 2006-12-31 | CN¥2.95 Billion ≈ $432.15 Million |
CN¥384.56 Million ≈ $56.27 Million |
0.130x | +94.71% |
| 2005-12-31 | CN¥2.86 Billion ≈ $419.10 Million |
CN¥191.54 Million ≈ $28.03 Million |
0.067x | -58.24% |
| 2004-12-31 | CN¥2.60 Billion ≈ $379.96 Million |
CN¥415.82 Million ≈ $60.85 Million |
0.160x | +10.43% |
| 2003-12-31 | CN¥2.00 Billion ≈ $292.58 Million |
CN¥289.94 Million ≈ $42.43 Million |
0.145x | -4.40% |
| 2002-12-31 | CN¥1.65 Billion ≈ $241.77 Million |
CN¥250.61 Million ≈ $36.67 Million |
0.152x | -4.13% |
| 2001-12-31 | CN¥1.45 Billion ≈ $212.88 Million |
CN¥230.18 Million ≈ $33.68 Million |
0.158x | +6.30% |
| 2000-12-31 | CN¥1.13 Billion ≈ $164.95 Million |
CN¥167.79 Million ≈ $24.55 Million |
0.149x | +100.35% |
| 1999-12-31 | CN¥758.76 Million ≈ $111.03 Million |
CN¥56.37 Million ≈ $8.25 Million |
0.074x | -65.28% |
| 1998-12-31 | CN¥677.52 Million ≈ $99.14 Million |
CN¥144.96 Million ≈ $21.21 Million |
0.214x | -- |
About Beijing Tongrentang Co Ltd
Beijing Tongrentang Co., Ltd engages in the research, production, distribution, and sale of Chinese patent medicines in China and internationally. It operates through the Company, Science Company, Commerce Company, and Others segments. The company offers various product dosage forms, such as pills, powders, alcoholic preparations, capsules, oral liquids, and dripping pills. Its products are used … Read more